PW507

PW507 is a potent and selective sigma-1 receptor (S1R) antagonist (Ki = 7.5 nM) with demonstrated blood-brain barrier penetration. It is a research tool used in preclinical studies, particularly for investigating mechanisms and potential treatments for painful diabetic neuropathy (PDN) in vivo and in vitro.